Aortic Stent Graft Market Scope And Analysis

Report Code : TIPHE100000878
Category : Life Sciences

No. of Pages : 150

Buy Now

Aortic Stent Grafts Market Analysis Report 2021-2031

Buy Now

Aortic Stent Grafts Market Report Scope

Report Attribute	Details
Market size in 2023	US$ 2.49 Billion
Market Size by 2031	US$ 4.04 Billion
Global CAGR (2023 - 2031)	6.2%
Historical Data	2021-2023
Forecast period	2023-2031
Segments Covered	By Product Abdominal Aortic Stent Graft and Thoracic Aortic Stent Graft By End User Hospitals and Ambulatory Surgical Centers
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	ENDOLOGIX INC Terumo Corporation Radcliffe Medical Media Cook MicroPort Scientific Corporation Corcym LeMaitre Vascular Inc W L Gore Associates Inc JOTEC GmbH

Industry Developments and Future Opportunities:

The aortic stent grafts market forecast can help stakeholders in this marketplace plan their growth strategies. As per press releases by key players operating in the market, a few initiatives are listed below:

In September 2023, MicroPort Endovastec's three aortic intervention products were approved by the Thailand Food and Drug Administration (TFDA). These products include the Castor Branched Aortic Stent-Graft and Delivery System, the Minos Abdominal Aortic Stent-Graft and Delivery System, and the Hercules Thoracic Stent Graft System with Low Profile Delivery System. These products were developed to treat thoracic and abdominal aortic diseases and are now registered and approved for use in Thailand.
In March 2023, Bolton Medical, Inc. received U.S. Food & Drug Administration (FDA) approval for its RelayPro Thoracic Stent-Graft System. The system comprises a delivery catheter and tube-shaped implants, called stent grafts, made of nitinol, polyester, and platinum-iridium. It is used to repair damage in the aorta, specifically in the area behind the heart, known as the descending thoracic aorta.
In March 2023, Vector Biolabs announced the completion of a facility expansion. The newly constructed facility has office space, warehouses, QC labs, and a cleanroom manufacturing suite. The company stated that, with the extra capacity, Vector will be able to continue providing its fast response times even as field demand grows and expand its offering to include new product characterization and quality control services.
In May 2021, Endologix LLC launched ALTO Abdominal Stent Graft in Canada after receiving approval from Health Canada, and it has also received commercial approval for it in Argentina. With the launch of this latest Endovascular Aneurysm Repair (EVAR) technology, the company aims to expand its global reach in the market.

Competitive Landscape and Key Companies:

ENDOLOGIX INC; Terumo Corporation; Radcliffe Medical Media; Cook; MicroPort Scientific Corporation; Corcym; LeMaitre Vascular, Inc; W. L. Gore & Associates, Inc.; JOTEC GmbH; and Medtronic are among the prominent players profiled in the aortic stent grafts market report. These companies focus on new technologies, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios.